Recombinant Human DBNL Protein (HEK293)，Strep & His

DBNL (Drebrin, an actin-binding protein) is a member of the drebrin family, which plays a critical role in the cytoskeletal organization and cellular signaling processes. The research into DBNL recombinant proteins has gained significance due to its crucial involvement in various physiological and pathological conditions, including synaptic plasticity, memory formation, and neurodegenerative disorders. DBNL interacts with the actin cytoskeleton, influencing dendritic spine morphology and function, thus making it an essential factor in neuronal health and development. Moreover, abnormalities in DBNL expression or function can contribute to the progression of diseases such as Alzheimer's, where synaptic degradation is a hallmark. The ability to produce DBNL as a recombinant protein facilitates the exploration of its biochemical properties, functional mechanisms, and potential interactions with other signaling molecules. Studies using recombinant DBNL can lead to a better understanding of its role in cellular processes and may provide insights into therapeutic strategies for treating neurodegenerative diseases. Given the growing interest in the cytoskeletal dynamics in cell motility and signaling, the characterization of DBNL and its interactions can pave the way for innovative approaches in neuroscience research and potential drug development. This research area is not only relevant for comprehending basic cellular functions but also has implications for developing interventions in neurobiology, thereby highlighting the importance of DBNL studies in both basic and applied science.